Citation

Grau K, Fegert JM, Allroggen M. Z. Kinder Jugendpsychiatr Psychother. 2015; 43(1): 29-37.

Copyright

(Copyright © 2015, Verlag Hans Huber)

DOI

10.1024/1422-4917/a000330

PMID

unavailable

Abstract

Body dysmorphic disorder (BDD) is a relatively common disorder with a point prevalence of 0.7-2.4%. BDD is characterized by the patient's excessive concern with an imagined or slight defect in physical appearance. BDD usually begins in adolescence. Comorbidity rates and also suicidality rates are high. The course of BDD tends to be chronic. According to the present state of knowledge, cognitive-behavioral therapy and pharmacotherapy with selective serotonin reuptake inhibitors are valuable options in the therapy of BDD. The case report describes a recent case of BDD with typical clinical and therapy-related characteristics. The aim of this work is to strengthen the awareness of BDD in clinical practice of child and adolescent psychiatry, facilitating an adequate diagnosis and treatment of the affected individuals. © 2015 Verlag Hans Huber, Hogrefe AG, Bern.

Language: de

Keywords

Humans; Cross-Sectional Studies; Risk Factors; adolescent; Child; Female; Male; human; Adolescent; suicide; child; female; male; Comorbidity; Patient Admission; Suicidal Ideation; case report; suicidal ideation; Follow-Up Studies; comorbidity; Pharmacotherapy; psychology; Absenteeism; Combined Modality Therapy; risk factor; child psychiatry; hospital admission; serotonin uptake inhibitor; cognitive therapy; follow up; cross-sectional study; absenteeism; body dysmorphic disorder; Cognitive-behavioral therapy; Body dysmorphic disorder; multimodality cancer therapy; Phobic Disorders; Dysmorphophobia; Article; Cognitive Therapy; Pyrimidines; pyrimidine derivative; Body Dysmorphic Disorders; fluoxydine